Log In
BCIQ
Print this Print this
 

Pan-Antigen Cytotoxic Therapy (ComPACT)

  Manage Alerts
Collapse Summary General Information
Company Heat Biologics Inc.
DescriptionPan-antigen T cell priming vaccine and co-stimulator targeting co-stimulatory receptors tumor necrosis factor (TNF) receptor superfamily member 4 (TNFRSF4; OX40; CD134), inducible T cell co-stimulator (ICOS) and TNFRSF9; 4-1BB; CD137
Molecular Target Inducible T cell co-stimulator (ICOS) ; Tumor necrosis factor (TNF) receptor superfamily member 4 (OX40) (TNFRSF4) (CD134)
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today